2006, Número 4
<< Anterior Siguiente >>
Med Cutan Iber Lat Am 2006; 34 (4)
Dermatitis de contacto por parafenilenodiamina: una sensibilización con múltiples problemas
Vilaplana J, Romaguera C
Idioma: Español
Referencias bibliográficas: 33
Paginas: 173-178
Archivo PDF: 264.63 Kb.
RESUMEN
Mujer de 52 años, ama de casa, a quien en los últimos diez años se le han practicado en tres ocasiones pruebas epicutáneas. En enero de 1993 la serie estándar y la serie de peluqueria por alergia a un tinte capilar; en marzo de 1996 la serie de calzado y finalmente en marzo del 2003 la serie textil por presentar eccema de contacto producido por unos pantalones. En los tres casos solo se obtuvo positividad a la parafenilenodiamina (PPD), sin ninguna reacción cruzada.
REFERENCIAS (EN ESTE ARTÍCULO)
Conde-Salazar L, del-Rio E, Guimaraens D, Gonzalez Domingo A. Type IV allergy to rubber additives: a 10-year study of 686 cases. J Am Acad Dermatol. 1993;29:176-80.
Seidenari S, Giusti F, Massone F, Mantovani L. Sensitization to disperse dyes in a patch test population over a fi ve-year period. Am J Contact Dermat. 2002;13:101-7.
Fautz R, Fuchs A, van der Walle H, Henny V, Smits L. Hair dye-sensitized hairdressers: the cross-reaction pat tern with new generation hair dyes. Contact Dermatitis. 2002;46:319-24.
Goon AT, Gilmour NJ, Basket ter DA, White IR, Rycroft RJ, McFadden JP. High frequency of simultaneous sensitivity to Disperse Orange 3 in patients with positive patch tests to para-phenylenediamine. Contact Dermatitis. 2003;48:248-50.
5 . Nakagawa M, Kawai K, Kawai K. Multiple azo disperse dye sensitization mainly due to group sensitizations to azo dyes. Contact Dermatitis. 1996;34:6-11.
Seidenari S, Giusti F, Massone F, Mantovani L. Sensitization to disperse dyes in a patch test population over a fi ve-year period. Am J Contact Dermat. 2002;13:101-7.
Goon AT, Gilmour NJ, Basket ter DA, White IR, Rycroft RJ, McFadden JP. High frequency of simultaneous sensitivity to Disperse Orange 3 in patients with positive patch tests to para-phenylenediamine. Contact Dermatitis. 2003;48:248-50.
Epstein E. Shoe contact dermatitis. JAMA. 1969;209:1487-92.
Leppard BJ, Parhizgar B. Contact dermatitis to PPD rubber in Maleki shoes. Contact Dermatitis. 1977;3:91-3.
Romaguera C, Grimalt F, Vilaplana J. Shoe contact dermatitis. Contact Dermatitis. 1988;18):178.
Romaguera C, Vilaplana J. Contact dermatitis in children: 6 years experience (1992-1997). Contact Dermatitis. 1998;39:277-80.
Wolf R, Orion E, Matz H. Contact dermatitis in military personnel. Clin Dermatol. 2002;20:439-44. Review
Trattner A, Farchi Y, David M. Shoe contact dermatitis in Israel. Am J Contact Dermat. 2003;14:12-4.
Munsey WF. Diphenhydramine for local anesthesia in caine sensitive patients. A case report. J Am Podiatry Assoc. 1966;56: 25-6.
Levy SM, Baker KA. Considerations in differential diagnosis of adverse reactions to local anesthetic: report of case. J Am Dent Assoc. 1986;113:271-3.
Ruzicka T, Gerstmeier M, Ring J. Allergy to local anesthetics Z Hautkr. 1987;62:455-60.
Beck MH, Holden A. Benzocaine- -an unsatisfactory indicator of topical local anaesthetic sensitization for the U.K. Br J Dermatol. 1988;118:91-4.
Enders F, Przybilla B, Ring J, Burg G, Braun-Falco O. Epicutaneous testing with a standard series. Results in 12,026 patients. Hautarzt. 1988;39:779-86.
Kreilgard B, Hansen J, Fischer T. Chemical, pharmaceutical and clinical standardization of the TRUE Test caine mix. Contact Dermatitis. 1989;21:23-7.
Sidhu SK, Shaw S, Wilkinson JD. A 10-year retrospective study on benzocaine allergy in the United Kingdom. Am J Contact Dermat. 1999;10:57-61.
Holtzer CD, Flaher ty JF Jr, Coleman RL. Cross-react ivi ty in HIV-infected patients switched from trimethoprim sulfamethoxazole to dapsone. Pharmacotherapy. 1998;18:831-5.
Schnyder B, Burkhart C, Schnyder-Frutig K, von Greyerz S, Naisbitt DJ, Pirmohamed M, Park BK, Pichler WJ. Recognition of sulfamethoxazole and its reactive metabolites by drug-specifi c CD4+ T cells from allergic individuals. J Immunol. 2000;164:6647-54.
Strom BL, Schinnar R, Apter AJ, Margolis DJ, Lautenbach E, Hennessy S, Bilker WB, Pettitt D. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med. 2003;349:1628-35.
Saxon A, Macy E. Cross-reactivity and sulfonamide antibiotics. N Engl J Med. 2004;350:302-3; author reply 302-3.
Negreiros EB, Almeida CA, de Viveiros MB, Cury J. [Sensitization to the para group: a constant or occasional phenomenon?] Rev Bras Med. 1966;23:236-7.
Dungemann H, Borelli S. [Studies on group allergies of aromatic amino compounds. Test results on so-called „para group“ allergies] Berufsdermatosen. 1966;14:281-95.
Gontijo J. Drug-induced dermatoses caused by substances of the para group. Hospital (Rio J). 1968;73:1225-43.
Kleniewska D. Studies on hypersensitivity to para group. Berufsdermatosen. 1975;23:31- 6.
Kleniewska D, Rudzki E. Allergy pattern to Para group compounds. Przegl Dermatol. 1976;(6 Suppl):251-3.
Seidenari S, Mantovani L, Manzini BM, Pignatti M. Cross-sensitizations between azo dyes and para-amino compound. A study of 236 azo-dye-sensitive subjects. Contact Dermatitis. 1997;36:91-6.
Lisi P, Hansel K. Is benzoquinone the prohapten in cross-sensitivity among aminobenzene compounds? Contact Dermatitis. 1998;39:304-6.
Uter W, Lessmann H, Geier J, Becker D, Fuchs T, Richter G; IVDK Study Group; German Contact Dermatitis Research Group (DKG). The spectrum of allergic (cross-) sensitivity in clinical patch testing with para amino compounds. Allergy. 2002;57:319-22.
Dawe S, White I, Rycroft R, Mc Fadden J. A 10-years review to determine wether exposure to p-phenilenediamine during patch-test leads to sensitization. Contact Dermatitis 2004;50:128.